Results 31 to 40 of about 2,942 (146)
Journal of Toxicology, Volume 2012, Issue 1, 2012., 2012 While phospholipidosis is thought to be an adaptive response to chemical challenge, many phospholipogenic compounds are known to display adverse effects in preclinical species and humans. To investigate the link between phospholipogenic administration and incidence of preclinical histological signals, an internal AstraZeneca in vivo toxicology report ...
Linda R. Barone +5 more
wiley +1 more source
Gaucher Disease and the Synucleinopathies
BioMed Research International, Volume 2006, Issue 1, 2006., 2006 Several recent observations suggest a connection between Gaucher disease, the inherited deficiency of glucocerebrosidase, and the synucleinopathies. Rare patients have been observed who develop both Gaucher disease and parkinsonism. Autopsy studies on these subjects reveal synuclein‐positive Lewy bodies and inclusions.
Kathleen S. Hruska +2 more
wiley +1 more source
Functional Ecology, Volume 40, Issue 6, Page 1906-1920, June 2026.Read the free Plain Language Summary for this article on the Journal blog. Abstract Human‐driven landscape change, particularly urbanization, is reshaping pollinator communities, yet the functional traits that mediate species persistence remain poorly understood. Dietary specialization is commonly used to predict species vulnerability.
Yan Yang +5 more
wiley +1 more source
Muscle &Nerve, Volume 71, Issue 2, Page 229-236, February 2025.ABSTRACT Introduction/Aim Patients with myotonic dystrophy type1 (DM1) have reduced lifespan. This study aimed to quantify mortality risks, and evaluate causes and time trends in DM1. Methods We identified 1021 DM1 patients and 15,104 matched DM1‐free controls from the United Kingdom (UK) Clinical Practice Research Datalink.
Rotana Alsaggaf +5 more
wiley +1 more source
Old disease—New reflections: Gaucher, immunity, and inflammation
Journal of Cellular and Molecular Medicine, Volume 28, Issue 20, October 2024.Abstract Gaucher disease (GD) is the most common lysosomal storage disease. It is a multisystemic metabolic disease caused by GBA pathogenic mutations. Although the general symptoms have been known for a long time, new treatment possibilities, the detection of different biomarkers, and innovations in diagnosis and follow‐up have paved the way for ...
Can Veysel Şoroğlu, Ezgi Gizem Berkay
wiley +1 more source
Abstract Book: 25th Congress of the European Hematology Association Virtual Edition, 2020
, 2020 HemaSphere, Volume 4, Issue S1, Page 1-1168, June 2020.
wiley +1 more source
Prenatal diagnosis of perplexing cases of lipidoses
Bratislava Medical Journal, 2008 To present and discuss the technical, ethical and counseling difficulties that were encountered in the prenatal diagnosis of some perplexing cases of lipidoses.Four pregnant women were referred to us for prenatal diagnosis with the diagnosis of lipidosis in an affected sibling.(1) It is recommended to do the enzyme assays as the first choice in all ...
Ahmed L, Aboul Nasr, Ekram M, Fateen
openaire +2 more sources
Influence of the Reproductive and Non-Reproductive Season on Hepatic Fat Accumulation in Trachemys sp.: Correlations of Computed Tomography, Histopathology, Biochemistry and Coelioscopy. [PDF]
Anat Histol EmbryolRolim LS +7 more
europepmc +1 more source